Cargando…
Anti-inflammatory and chondroprotective effects of the S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin A, in human articular chondrocytes
3-Deazaneplanocin A (DZNep) is an inhibitor of S-Adenosyl-L-Homocysteine Hydrolase (SAHH) known to inhibit EZH2, a histone methylase upregulated during osteoarthritis. In this study, we assessed its effects in human articular chondrocytes. Anti-inflammatory effects were assessed by Nitric Oxide (NO)...
Autores principales: | Aury-Landas, Juliette, Bazille, Céline, Allas, Lyess, Bouhout, Sara, Chesneau, Christophe, Leclercq, Sylvain, Boumédiene, Karim, Baugé, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526903/ https://www.ncbi.nlm.nih.gov/pubmed/28744016 http://dx.doi.org/10.1038/s41598-017-06913-6 |
Ejemplares similares
-
Evaluation of the impact of S-adenosylmethionine-dependent methyltransferase inhibitor, 3-deazaneplanocin A, on tissue injury and cognitive function in mice
por: Lhuissier, Eva, et al.
Publicado: (2018) -
Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas
por: Lhuissier, Eva, et al.
Publicado: (2021) -
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
por: Girard, Nicolas, et al.
Publicado: (2014) -
Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas
por: Lhuissier, Eva, et al.
Publicado: (2017) -
EZH2 inhibition reduces cartilage loss and functional impairment related to osteoarthritis
por: Allas, Lyess, et al.
Publicado: (2020)